456
Participants
Start Date
June 17, 2021
Primary Completion Date
December 3, 2024
Study Completion Date
December 21, 2024
AXS-05 (dextromethorphan-bupropion)
AXS-05 tablets, taken twice daily
Placebo
Placebo tablets, taken twice daily
Clinical Research Site, Staten Island
Clinical Research Site, Brooklyn
Clinical Research Site, New Windsor
Clinical Research Site, Arlington
Clinical Research Site, Charlotte
Clinical Research Site, Hickory
Clinical Research Site, Columbus
Clinical Research Site, Lake City
Clinical Research Site, Orlando
Clinical Research Site, Hialeah
Clinical Research Site, Miami Gardens
Clinical Research Site, Miami Lakes
Clinical Research Site, Hollywood
Clinical Research Site, Pembroke Pines
Clinical Research Site, Coral Springs
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Greenacres City
Clinical Research Site, Brandon
Clinical Research Site, Tampa
Clinical Research Site, Tampa
Clinical Research Site, Bonita Springs
Clinical Research Site, Trinity
Clinical Research Site, Kissimmee
Clinical Research Site, Rochester Hills
Clinical Research Site, Flint
Clinical Research Site, Chesterfield
Clinical Research Site, Wichita
Clinical Research Site, Mesquite
Clinical Research Site, Cypress
Clinical Research Site, Sugar Land
Clinical Research Site, Austin
Clinical Research Site, Peoria
Clinical Research Site, Tempe
Clinical Research Site, Long Beach
Clinical Research Site, Temecula
Clinical Research Site, Santa Ana
Clinical Research Site, Walnut Creek
Clinical Research Site, Braintree
Clinical Research Site, Toms River
Clinical Research Site, Kelowna
Clinical Research Site, San Juan
Lead Sponsor
Axsome Therapeutics, Inc.
INDUSTRY